A Feb. 10 meeting is open to to 30 individuals representing manufacturers who have previously submitted an ENDS premarket ...
FDA written feedback supports:- a single-arm, open-label registrational trial in 2nd-line refractory high-grade NMIBC with CIS- a randomized vs ...
Advicenne (Euronext Growth Paris - FR0013296746 - ALDVI), a pharmaceutical company specializing in the development and marketing of innovative treatments for people suffering from rare kidney diseases ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback